Systemic versus local delivery of marrow stromal cells in cells in a rodent stroke model

Kaveh Shariat, Frank Ahlhelm, Máté D. Döbrössy, Guido Nikkhah & Robert D. Kirch
Objective: Ischemic stroke accounts for ~80% of all cases presented. Currently, mechanical recanalization and thrombolysis are the only available short-term therapies available. Numerous experimental studies have shown a functional improvement after stem cell administration during the acute[for full text, please go to the a.m. URL]